# PSP Research LLC 13F holdings Q2 2026: $188 million

PSP Research LLC reported $188 million in 13F securities across 75 positions for the quarter ended June 30, 2026, in a holdings report filed July 9, 2026. Its largest holding was SPDR Series Trust at $90.2 million, 48.0% of the reported value. Since Q1 2026 it opened 11 new positions and exited 15.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $187,882,190
- Positions: 75
- Filed: July 9, 2026
- Report type: 13F holdings report
- CIK: 2106939
- Form 13F file number: 028-26116
- Business address: 113 Tiller Point Street, Las Vegas, NV 89138
- SEC filing: [0001951757-26-000944](https://www.sec.gov/Archives/edgar/data/2106939/000195175726000944/0001951757-26-000944-index.htm)

## Top 25 holdings by value

The largest of 75 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [SPDR Series Trust](https://specstream.ai/data/institutional-holders/spdr-series-trust-78464a870) | ST STR SP BIOT | 570,000 | $90.2 million | +285,100 |
| [Ishares TR](https://specstream.ai/data/institutional-holders/ishares-tr-46436e718) | 0-3 MTH TREASURY | 700,000 | $70.5 million | No change |
| [Royalty Pharma PLC](https://specstream.ai/data/institutional-holders/royalty-pharma-plc-g7709q104) | SHS CLASS A | 11,000 | $616,770 | No change |
| [Nurix Therapeutics Inc](https://specstream.ai/data/institutional-holders/nurix-therapeutics-inc-67080m103) | COM | 25,000 | $606,500 | -3,700 |
| [Incyte Corp](https://specstream.ai/data/institutional-holders/incyte-corp-45337c102) | COM | 5,300 | $600,808 | No change |
| [Argenx Se](https://specstream.ai/data/institutional-holders/argenx-se-04016x101) | SPONSORED ADR | 641 | $594,701 | No change |
| [Disc Medicine Inc](https://specstream.ai/data/institutional-holders/disc-medicine-inc-254604101) | COM | 8,000 | $585,120 | No change |
| [Rapport Therapeutics Inc](https://specstream.ai/data/institutional-holders/rapport-therapeutics-inc-75383l102) | COM | 14,000 | $583,380 | No change |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 17,000 | $567,630 | -5,100 |
| [Trevi Therapeutics Inc](https://specstream.ai/data/institutional-holders/trevi-therapeutics-inc-89532m101) | COM | 30,000 | $559,500 | No change |
| [Monte Rosa Therapeutics Inc](https://specstream.ai/data/institutional-holders/monte-rosa-therapeutics-inc-61225m102) | COM | 23,000 | $556,600 | -5,000 |
| [TG Therapeutics Inc](https://specstream.ai/data/institutional-holders/tg-therapeutics-inc-88322q108) | COM | 10,000 | $549,400 | -3,000 |
| [Halozyme Therapeutics Inc](https://specstream.ai/data/institutional-holders/halozyme-therapeutics-inc-40637h109) | COM | 7,000 | $547,890 | -1,026 |
| [Ionis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ionis-pharmaceuticals-inc-462222100) | COM | 6,800 | $539,172 | No change |
| [Pharvaris N V](https://specstream.ai/data/institutional-holders/pharvaris-n-v-n69605108) | COM | 15,000 | $518,700 | -5,000 |
| [Arcutis Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/arcutis-biotherapeutics-inc-03969k108) | COM | 19,700 | $516,534 | No change |
| [Aurinia Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/aurinia-pharmaceuticals-inc-05156v102) | COM | 30,000 | $509,100 | No change |
| [Neurocrine Biosciences Inc](https://specstream.ai/data/institutional-holders/neurocrine-biosciences-inc-64125c109) | COM | 3,000 | $505,605 | -848 |
| [Immunovant Inc](https://specstream.ai/data/institutional-holders/immunovant-inc-45258j102) | COM | 13,000 | $500,890 | -6,200 |
| [Acadia Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/acadia-pharmaceuticals-inc-004225108) | COM | 19,766 | $500,080 | No change |
| [PTC Therapeutics Inc](https://specstream.ai/data/institutional-holders/ptc-therapeutics-inc-69366j200) | COM | 6,000 | $489,420 | No change |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 13,000 | $483,730 | No change |
| [Immunocore Hldgs PLC](https://specstream.ai/data/institutional-holders/immunocore-hldgs-plc-45258d105) | ADS | 15,141 | $480,727 | No change |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 10,000 | $470,400 | -24,800 |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 12,000 | $464,400 | No change |

## New positions in Q2 2026

11 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 1,500 | $400,080 |
| [Liquidia Corporation](https://specstream.ai/data/institutional-holders/liquidia-corporation-53635d202) | COM NEW | 5,000 | $398,650 |
| [Krystal Biotech Inc](https://specstream.ai/data/institutional-holders/krystal-biotech-inc-501147102) | COM | 692 | $257,196 |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 7,041 | $244,604 |
| [Jazz Pharmaceuticals PLC](https://specstream.ai/data/institutional-holders/jazz-pharmaceuticals-plc-g50871105) | SHS USD | 971 | $233,982 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 1,200 | $224,736 |
| [Rhythm Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/rhythm-pharmaceuticals-inc-76243j105) | COM | 2,000 | $222,060 |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 8,463 | $217,668 |
| [Arrowhead Pharmaceuticals in](https://specstream.ai/data/institutional-holders/arrowhead-pharmaceuticals-in-04280a100) | COM | 2,600 | $211,926 |
| [Scholar Rock HLDG Corp](https://specstream.ai/data/institutional-holders/scholar-rock-hldg-corp-80706p103) | COM | 3,827 | $210,485 |
| [Cytomx Therapeutics Inc.](https://specstream.ai/data/institutional-holders/cytomx-therapeutics-inc-23284f105) | COM | 39,400 | $147,750 |

## Positions exited in Q2 2026

15 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Sera Prognostics Inc](https://specstream.ai/data/institutional-holders/sera-prognostics-inc-81749d107) | CLASS A COM | 2,396,685 | $4.9 million |
| [Tyra Biosciences Inc](https://specstream.ai/data/institutional-holders/tyra-biosciences-inc-90240b106) | COM | 16,000 | $612,800 |
| Ascendis Pharma A/S | SPONSORED ADR | 2,500 | $571,825 |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 8,300 | $547,053 |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 15,000 | $507,450 |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 1,500 | $483,285 |
| [Inhibrx Biosciences Inc](https://specstream.ai/data/institutional-holders/inhibrx-biosciences-inc-45720n103) | COM | 6,927 | $465,702 |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 17,327 | $280,351 |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 2,000 | $228,280 |
| Kalvista Pharmaceuticals Inc | COM | 10,795 | $217,303 |
| [Legend Biotech Corp](https://specstream.ai/data/institutional-holders/legend-biotech-corp-52490g102) | SPONSORED ADS | 12,000 | $217,080 |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 2,500 | $210,425 |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 350 | $207,543 |
| [Summit Therapeutics Inc](https://specstream.ai/data/institutional-holders/summit-therapeutics-inc-86627t108) | COM | 10,223 | $193,828 |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 30,000 | $158,700 |

## Also on SpecStream

- [PSP Research LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/2106939/000195175726000944/0001951757-26-000944-index.htm)
- [Largest 13F filers in Nevada](https://specstream.ai/data/institutional-holdings/state/nevada)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Las Vegas, Nevada

- [Preschools in Las Vegas, Nevada](https://specstream.ai/data/businesses/preschools/las-vegas-nevada-united-states)
- [Physical therapy clinics in Las Vegas, Nevada](https://specstream.ai/data/businesses/physical-therapy-clinics/las-vegas-nevada-united-states)
- [Outpatient care facilities in Las Vegas, Nevada](https://specstream.ai/data/businesses/outpatient-care-facilities/las-vegas-nevada-united-states)
- [Nursing services in Las Vegas, Nevada](https://specstream.ai/data/businesses/nursing-services/las-vegas-nevada-united-states)
- [Middle schools in Las Vegas, Nevada](https://specstream.ai/data/businesses/middle-schools/las-vegas-nevada-united-states)
- [Medical service organizations in Las Vegas, Nevada](https://specstream.ai/data/businesses/medical-service-organizations/las-vegas-nevada-united-states)
